Markus Schick

896 citations

24 papers · 320 indexed · h-index 11

Impact in

Oncology
- Peptidase Inhibition and Analysis
- Lung Cancer Research Studies
Molecular Biology
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- RNA modifications and cancer
- Histone Deacetylase Inhibitors Research

Papers in ⓘ

Oncology 13
- Lung Cancer Research Studies 4
- Peptidase Inhibition and Analysis 4
- Cancer Immunotherapy and Biomarkers 3
Molecular Biology 12
- Ubiquitin and proteasome pathways 6
- Protein Degradation and Inhibitors 3

Co-authors: Ulrich Keller (12 shared papers)Stefan Habringer (3 shared papers)Jonas A. Nilsson (1 shared paper)Matthias Wirth (6 shared papers)Sheng Li (1 shared paper)Günter Schneider (2 shared papers)Irina Gostimskaya (1 shared paper)Blanche Schwappach (1 shared paper)
Journals: Molecular Cancer (2 papers)Scientific Reports (1 paper)British Journal of Cancer (1 paper)British Journal of Haematology (1 paper)Cell Reports (1 paper)
Partner nations: Germany United States United Kingdom

In The Last Decade

Markus Schick

22 papers receiving 318 citations

Peers

Countries citing papers authored by Markus Schick

Since Specialization

Citations

This map shows the geographic impact of Markus Schick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Schick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Schick more than expected).

Fields of papers citing papers by Markus Schick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Schick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Schick. The network helps show where Markus Schick may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Schick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Schick Line = papers co-authored together Markus Schick links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Protein Targeting Factor Get3 Functions as ATP-Independent Chaperone under Oxidative Stress Conditions Molecular Cell ·Wilhelm Voth, Markus Schick, Stephanie N. Gates, Sheng Li, Fabio Vilardi, Irina Gostimskaya, Daniel R. Southworth, Blanche Schwappach, Ursula Jakob	2014	55
2	The SUMO Isopeptidase SENP6 Functions as a Rheostat of Chromatin Residency in Genome Maintenance and Chromosome Dynamics Cell Reports ·Kristina Wagner, Kathrin Kunz, Tanja Piller, Georg Tascher, Soraya Hölper, Per Stehmeier, Jan Keiten‐Schmitz, Markus Schick, Ulrich Keller, Stefan Müller	2019	50
3	Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers British Journal of Haematology ·Markus Schick, Stefan Habringer, Jonas A. Nilsson, Ulrich Keller	2017	36
4	The SUMO pathway in pancreatic cancer: insights and inhibition British Journal of Cancer ·Christian Schneeweis, Zonera Hassan, Markus Schick, Ulrich Keller, Günter Schneider	2020	24
5	NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer Proceedings of the National Academy of Sciences ·Josefina Doffo, Stefanos A. Bamopoulos, Hazal Köse, Felix Orben, Chuanbing Zang, Miriam Pons, Alexander T. den Dekker, Rutger W. W. Brouwer, Apoorva Baluapuri, Stefan Habringer, Maximillian Reichert, Anuradha Illendula, Oliver H. Krämer, Markus Schick, Elmar Wolf, Wilfred F. J. van IJcken, Iréne Esposito, Ulrich Keller, Günter Schneider, Matthias Wirth	2022	22
6	Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study Molecular Cancer ·Mingchao Xie, Miljenka Vuko, Jaime Rodriguez‐Canales, Johannes Zimmermann, Markus Schick, Cathy O’Brien, Luis Paz‐Ares, Jonathan W. Goldman, Marina Chiara Garassino, Carl M. Gay, John V. Heymach, Haiyi Jiang, J. Carl Barrett, Ross Stewart, Zhongwu Lai, Lauren A. Byers, Charles M. Rudin, Yashaswi Shrestha	2024	21
7	Ubiquitination and Ubiquitin-Like Modifications in Multiple Myeloma: Biology and Therapy Cancers ·Matthias Wirth, Markus Schick, Ulrich Keller, Jan Krönke	2020	20
8	Activated gp130 signaling selectively targets B cell differentiation to induce mature lymphoma and plasmacytoma JCI Insight ·Anna Katharina Scherger, Mona Al-Maarri, H. Carlo Maurer, Markus Schick, Sabine Maurer, Rupert Öllinger, Irene González-Menéndez, Manuela Martella, Markus Thaler, Konstanze Pechloff, Katja Steiger, Sandrine Sander, Jürgen Ruland, Roland Rad, Leticia Quintanilla-Martı́nez, F. Thomas Wunderlich, Stefan Rose‐John, Ulrich Keller	2019	17
9	Autonomous progesterone secretion from the bovine corpus luteum in vitro European Journal of Endocrinology ·Winfried G. Rossmanith, Markus Schick, Reiner Benz, Christian Lauritzen	1991	17
10	HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer Scientific Reports ·Ansh Kapil, Andreas Spitzmüller, Nicolas Brieu, Susanne Haneder, Anatoliy Shumilov, Armin Meier, Franco Cecchi, Alice Barkell, Nathalie Harder, Katrin Mittermaier, Ana Hidalgo‐Sastre, Regina Alleze, Markus Schick, Günter Schmidt, Hadassah Sade, Zenta Tsuchihashi, Fumitaka Suto, Mark Gustavson, J. Carl Barrett, Danielle Carroll	2024	16
11	CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness Leukemia ·Richard Lewis, H. Carlo Maurer, Nikita Singh, Irene González-Menéndez, Matthias Wirth, Markus Schick, Le Zhang, Konstandina Isaakidis, Anna Katharina Scherger, Veronika Schulze, Junyan Lu, Thorsten Zenz, Katja Steiger, Roland Rad, Leticia Quintanilla-Martı́nez, Marion Espéli, Karl Balabanian, Ulrich Keller, Stefan Habringer	2021	13
12	MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma Blood Advances ·Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, Martina Emde-Rajaratnam, Hans Salwender, Uta Bertsch, Hartmut Goldschmidt, Katja Weisel, Christof Scheid, Ulrich Keller, Dirk Hose, Florian Bassermann	2021	7
13	REGGAE: a novel approach for the identification of key transcriptional regulators Bioinformatics ·Tim Kehl, Lara Schneider, Kathrin Kattler, Daniel Stöckel, Jenny Wegert, Nico Gerstner, Nicole Ludwig, Ute Distler, Markus Schick, Ulrich Keller, Stefan Tenzer, Manfred Gessler, Jörn Walter, Andreas Keller, Norbert Graf, Eckart Meese, Hans‐Peter Lenhof	2018	6
14	Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapy Haematologica ·Uta M. Demel, Matthias Wirth, Schayan Yousefian, Le Zhang, Konstandina Isaakidis, Judith Dönig, Marlitt Böger, Nikita Singh, Hazal Köse, Simon Haas, Stefan Müller, Markus Schick, Ulrich Keller	2022	5
15	Actionable loss of SLF2 drives B‐cell lymphomagenesis and impairs the DNA damage response EMBO Molecular Medicine ·Le Zhang, Matthias Wirth, Upayan Patra, Jacob Stroh, Konstandina Isaakidis, Leonie Rieger, Susanne Kossatz, Maja Milanovic, Chuanbing Zang, Uta M. Demel, Jan Keiten‐Schmitz, Kristina Wagner, Katja Steiger, Roland Rad, Florian Bassermann, Stefan Müller, Ulrich Keller, Markus Schick	2023	2
16	Authentication of Primary Murine Cell Lines by a Microfluidics-Based Lab-On-Chip System Biomedicines ·Ying‐Fen Hong, Nikita Singh, Stefanos A. Bamopoulos, Enio Gjerga, Laura K. Schmalbrock, Karl Balabanian, Markus Schick, Ulrich Keller, Matthias Wirth	2020	2
17	Utilizing Mask-Guided Cross-Image Attention for Zero-Shot In-Silico Histopathologic Image Generation with a Diffusion Model Dominik Winter, Nicolas Triltsch, Marco Rosati, Anatoliy Shumilov, Ziya Kokaragac, Yuri V. Popov, Thomas Padel, Laura Sebastián Monasor, Ross A. Hill, Markus Schick, Nicolas Brieu	2025	2
18	Abstract 2492: Enhanced patient selection for anti-PD-L1 treatment in metastatic NSCLC with quantitative continuous scoring of PD-L1 Cancer Research ·Jan Lesniak, Markus Schick, Thomas Kunzke, Federico Pollastri, Juan P. Vigueras-Guillén, Harald Hessel, Susanne Haneder, Pallavi Sontakke, Karma Dacosta, Regina Alleze, Hadassah Sade, J. Carl Barrett, Günter Schmidt, Ross Stewart	2024	1
19	1505 Spatial profiling of the SCLC tumor microenvironment defined by high MHC-I expression reveals association with functionally relevant antigen presentation SHILAP Revista de lepidopterología ·Miljenka Vuko, Felix Segerer, Mingchao Xie, Monica Azqueta Gavaldon, Andreas Spitzmüller, Harald Hessel, Alma Andoni, Marco Testori, Michael Surace, Mari Heininen‐Brown, Jaime Rodriguez Canales, Shashank Saran, Helen K. Angell, Günter Schmidt, Nicolas Brieu, Hadassah Sade, J Carl Barrett, Markus Schick, Giulia Fabbri	2023	1
20	583 Quantitative computational assessment of PD-L1 enables robust patient selection for biomarker-informed anti-PD-L1 treatment of NSCLC patients Regular and Young Investigator Award Abstracts ·Jan Lesniak, Markus Schick, Thomas Kunzke, Pallavi Sontakke, Thomas Padel, Anatoliy Shumilov, Farzad Sekhavati, Christian Carsten Sachs, Federico Pollastri, Ansh Kapil, (unknown), Nicolas Brieu, Carl Barrett, Hadassah Sade, Günter Schmidt, Ross Stewart	2022	1

About Markus Schick

Markus Schick is a scholar working on Oncology, Molecular Biology, Immunology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 24 papers that have together received 320 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Lung Cancer Research Studies (4 papers), Peptidase Inhibition and Analysis (4 papers), Protein Degradation and Inhibitors (3 papers), Cell Image Analysis Techniques (3 papers), Immune Cell Function and Interaction (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). The work is most often cited by research in Oncology (107 citations), Molecular Biology (209 citations), Hematology (32 citations), Aging (5 citations) and Cancer Research (39 citations). Markus Schick has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Ulrich Keller, Stefan Habringer, Jonas A. Nilsson, Matthias Wirth, Sheng Li, Günter Schneider, Irina Gostimskaya, Blanche Schwappach, Fabio Vilardi and Ursula Jakob. Their work appears in journals such as Molecular Cancer, Scientific Reports, British Journal of Cancer, British Journal of Haematology and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact